Retyping of triple‐negative breast cancer based on clustering method

Bo Liu,Xingrui Li,Huina Wang,Shuangtao Zhao,Jianqiang Li,Guangzhi Qu,Fei Wang

DOI: https://doi.org/10.1111/exsy.12583

IF: 3.3

2020-07-10

Expert Systems

Abstract:<p>Triple‐negative breast cancer is the worst prognosis in breast cancer, accounting for 10.0–20.8% of all breast cancers. Considering that triple‐negative breast cancer has great heterogeneity and very poor prognosis, clinical medication guidance is in urgent need of a more detailed classification of breast cancer itself. Although many researchers have been dedicated to the clustering of triple‐negative breast cancer and have found possible targets based on typing, their results are not closely related to the prognosis. This paper utilizes three clustering methods to retype the patient data with triple‐negative breast cancer, and the results show that the triple‐negative breast cancer data could be classified into two categories. Eight important genes and three important clinical factors related to the prognosis of two types of triple‐negative breast cancer have been obtained. These genes have the following three characteristics: co‐expression, differential expression and interaction. In terms of breast cancer control, the prognosis can be controlled as much as possible by regulating gene levels, which provides new directions and ideas for related research on breast cancer prognosis.</p>

computer science, artificial intelligence, theory & methods

What problem does this paper attempt to address?

The problem that this paper attempts to address is the reclassification of Triple-negative breast cancer (TNBC). TNBC is one of the most difficult types of breast cancer to treat due to its high heterogeneity and poor prognosis, accounting for 10.0% to 20.8% of all breast cancer cases. This type of breast cancer lacks effective targeted therapies because it is negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2). Currently, although many researchers are dedicated to clustering analysis of TNBC and have identified potential therapeutic targets based on subtypes, the results of these studies are not significantly associated with patient prognosis. Therefore, there is an urgent need for a more detailed classification method for breast cancer to guide clinical medication.

To this end, this paper utilizes three clustering methods (spectral clustering, hierarchical clustering, and K-means clustering) to reclassify TNBC patient data. The study results indicate that TNBC data can be classified into 2 categories, and 8 genes and 3 important clinical factors related to the prognosis of these 2 types of TNBC were identified. These genes exhibit characteristics of co-expression, differential expression, and interaction. By regulating the levels of these genes, the prognosis of breast cancer can be controlled to a certain extent, providing new directions and ideas for related research.